Transmissible Spongiform Encephalopathy

Introduction

Transmissible spongiform encephalopathies (TSEs), also called prion diseases, are rare degenerative brain disorders leading to tiny holes in the brain, giving it a spongy appearance. When viewed under a microscope, these holes are generally seen in the brain tissue. It can be considered an enigmatic group of rare neurodegenerative disorders that afflict humans and animals alike. TSEs have baffled researchers and clinicians for decades owing to their abnormal protein folding, leading to the formation of prion aggregates. This article discusses the intricacies of TSEs and mechanisms, examining their origins, clinical manifestations, and the obstacles faced with diagnosis and treatment.

What Is Transmissible Spongiform Encephalopathy (TSEs)?

TSEs are caused by prions – misfolded proteins that trigger a chain reaction of abnormal folding in normal proteins. The term ‘spongiform’ denotes the appearance of the brain tissue under a microscope, which gives it sponge-like holes caused by the loss of nerve cells. Prions are unique as they lack genetic material like DNA or RNA. The primary infectious agent in TSEs is a misfolded protein, mainly the prion protein (PrP).

How Is Transmissible Spongiform Encephalopathy (TSEs) Transmitted?

The origins of TSEs are multiple, ranging from sporadic cases to genetic mutations and acquired forms. Sporadic cases, like Creutzfeldt-Jakob disease (CJD), a rare, quickly worsening brain disorder that leads to distinctive changes in brain tissue and affects thinking, memory, and muscle coordination in humans. It is observed spontaneously without any visible cause. On the contrary, genetic mutations, especially in the PRNP gene, can expose individuals to familial forms of TSEs.

On the other hand, acquired forms can cause exposure to contaminated tissues or products, as observed in variant CJD associated with infected beef consumption during the bovine spongiform encephalopathy (BSE) epidemic. Transmission of TSEs is frequently seen through the consumption of infected tissues or contaminated medical procedures. Prions are highly resistant to standard sterilization methods, making transmission prevention a problematic task.

Human TSEs can be transmitted in three ways:

• Sporadically: It might develop when some of a person's normal prions spontaneously change into the infectious form of the protein and then change the prions in other cells in a chain reaction.

• Hereditary Diseases: Inherited cases are observed when an alteration or mutation in the prion protein gene causes the prions to be shaped abnormally. This genetic alteration can be transmitted to the individual's offspring.

• Transmission From Infected Individuals: Transmission of TSEs from infected individuals is observed rarely. TSEs are generally not transmitted through the air, through touching, or other forms of casual contact. However, they might be transmitted through contact with body fluids, infected tissue, or contaminated medical instruments. Standard sterilization procedures like boiling or irradiating materials do not ensure transmission prevention of TSEs.

What Are the Mechanisms of Pathogenesis?

The main characteristic of TSEs is converting the normal cellular prion protein (PrPC) into its abnormal form (PrPSc). The ‘Sc’ suffix represents ‘scrapie,’ a term that comes from a TSE in sheep. PrPSc has a varied three-dimensional structure than PrPC, and its accumulation in the brain stops normal cellular function.

The conversion of PrPC to PrPSc is a self-propagating procedure. PrPSc acts as a template, initiating the misfolding of adjacent PrPC molecules. This chain reaction is the aggregation of misfolded proteins, forming insoluble plaques in the brain. These plaques and neuronal death lead to the spongy appearance in affected brain tissue.

What Are the Clinical Manifestations?

TSEs manifest with a variety of neurological symptoms showing the widespread damage occurring in the brain. The following indicates the standard clinical features:

• Rapid cognitive decline.

• Personality changes.

• Coordination problems.

• Muscle stiffness.

As the disease progresses, patients might experience the following symptoms:

• Weakness.

• Muscle twitching.

• Severe neurological impairment.

The duration of TSEs might vary, with some forms progressing promptly within months, as observed in variant CJD, while others, like Gerstmann-Sträussler-Scheinker syndrome (a very rare neurodegenerative brain disorder), can have a longer course stretching over several years. The unfortunate part is that the clinical course of TSEs is irreversible, and it often leads to a fatal end.

How Is Transmissible Spongiform Encephalopathy (TSEs) Diagnosed?

Diagnosing TSEs is challenging. Clinical symptoms may overlap with other neurodegenerative disorders, and definitive diagnosis usually requires post-mortem examination of brain tissue. Magnetic resonance imaging (MRI) and cerebrospinal fluid analysis can give supportive evidence. However, the gold standard remains neuropathological examination.

Further, the long incubation periods in some forms of TSEs and the need for more reliable early diagnostic markers hinder early intervention efforts. The challenge in diagnosing TSEs emphasizes the need for ongoing research to develop more accessible and accurate diagnostic methods.

How to Prevent and Manage Transmissible Spongiform Encephalopathy (TSEs)?

Preventing TSEs involves control measures, strict surveillance, and research to develop practical diagnostic tools and treatments. As for human TSEs, public health measures include:

• Surveillance.

• Blood screening.

• Promoting safe practices in medical procedures.

In the case of animal TSEs, implementing measures like culling (reducing a wild animal population through selective slaughter) affected animals, restricting the use of potentially contaminated tissues, and monitoring the food supply chain is essential. However, since there is currently no cure for TSEs, management primarily focuses on supportive care to reduce symptoms and enhance the quality of life for affected individuals.

Conclusion

Transmissible spongiform 2 encephalopathy is a complex and confusing group of diseases with great implications for both human and animal health. The ability of prions to spread widely and induce irreversible damage in the brain highlights the need for ongoing research efforts. As the understanding of TSEs deepens, it is essential to implement preventive measures, enhance diagnostic capabilities, and explore new therapeutic interventions. Ongoing research is vital in understanding TSEs and developing strategies for prevention and treatment. Understanding the complexity of prion protein folding, exploring potential therapeutic interventions, and advancing diagnostic techniques are critical areas of investigation. Promising avenues include the development of prion protein inhibitors to impede the conversion of PrPC to PrPSc. Further, researchers are investigating the potential of immunotherapies and antiprion drugs to target and clear abnormal prion proteins from the brain. While these approaches are in the initial stages, they offer hope for future breakthroughs in TSE management.